About Curapath - A European CDMO for Non-Viral Drug Delivery
Curapath is a European Contract Development and Manufacturing Organization (CDMO) specialized in polymer- and lipid-based non-viral drug delivery systems and their components. This includes the development and manufacturing of polymer and lipid excipients, lipid nanoparticles (LNPs), polymer nanoparticles (PNPs), and advanced drug conjugation strategies. We support regulated biotech, pharmaceutical, and medical device programs from early development through GMP and commercial manufacturing.
Curapath offers a combination of off-the-shelf R&D and GMP-grade materials, as well as custom development services, enabling our partners to progress efficiently from early feasibility to scalable and regulatory-ready manufacturing. Our solutions include PEG alternatives, active targeting strategies for lipid nanoparticles (LNPs), and tunable transfection reagents, all designed with a strong focus on manufacturability, reproducibility, and long-term regulatory compliance, supporting both clinical and commercial supply of advanced delivery technologies.
Quick Facts
- Type of company:European Contract Development and Manufacturing Organization (CDMO)
- Specialization:Non-viral drug delivery systems
- Core technologies: Polymer and Lipid based delivery systems (LNPs,PNP,Polymer and Lipid excipients)
- Capabliities : R&D, GMP manufacturing, commercial supply
- Regulatory status: GMP certified, EMA inspected
- Markets adressed:Oncology, cell and gene therapy, DNA and mRNA vaccines, medical devices, in vivo CAR-T programs and trasfection reagents
Curapath’s
Core Values
We care
We develop our people.
We are customer centric.
We respect our suppliers.
Always with patients in mind.
We never give up
We think out of the box,
we design, test,
adapt and continuously improve.
We welcome problems
We strive for scientific innovation
and operational excellence to
create value in the market.
Why Choose Us
At Curapath, our top priority is delivering exceptional customer satisfaction. To maintain and enhance our service, we regularly conduct satisfaction surveys among our valued clients. Our current Net Promoter Score (NPS) stands at an astonishing 61, reflecting the high-level satisfaction from our customers and Curapath commitment in our customer-centric approach. We remain devoted to continuously improving this score through dedicated efforts and a focus on excellence.
Your Tailored Drug Delivery Solution
During an initial interaction, our technically proficient Business Development team will conduct a preliminary assessment of your needs. The primary objectives are to gain an understanding of your current development stage and the specific characteristics of your product at a high level, as well as to introduce Curapath’s capabilities.
A Project Manager will be appointed to support you and start building a project framework, by establishing requirements, planning timelines and defining deliverables. You will receive a preliminary time & budget proposal within 48 hours, once the project scope has been agreed.
Once the project gets started, your Project Manager will be your primary contact throughout the lifecycle of your project, providing progress reporting and walking you through the activities.
We prioritize quality standards and work efficiency in every project, ensuring that we not only meet but exceed our clients’ expectations. That’s why our average On-Time In-Full (OTIF) performance exceeds 93%, reflecting our unwavering commitment to customer satisfaction and excellence. This dedication to delivering projects on time and in full underscores our promise to provide reliable and high-quality service, reinforcing our position as a trusted partner in your success.
Project Management Support Every Step of the Way
Once your project gets started, a PMI-certified* Project Manager will actively participate from the very early interaction and accompany you throughout the entire project lifecycle, ensuing product quality compliance and on-time delivery.
Your appointed Project Manager will:
- Design and plan a customized project based on required milestones, deliverables, and budget.
- Report project progress and key data on the agreed frequency with transparency and honesty.
- Provide continuous technical advice and engage subject matter matter experts to the discussions when needed.
- Keep budgets on track and identify cost reductions wherever possible.
- Be flexible and adaptive to changes in project scope, requirements, or external factors that may impact the project.
- Apply agile methodologies, when possible, for continuous project improvement.
- Monitor and adjust schedules as necessary to ensure project milestones are met.
Frequently Asked Questions
What is Curapath
Curapath is a European Contract Development and Manufacturing Organization (CDMO) specialized in non-viral drug delivery systems. We support biotech and pharmaceutical companies from early development through GMP-ready and commercial manufacturing, combining proprietary delivery components, in-house technologies, and deep expertise in complex formulation and CMC development.
What type of drug delivery systems does Curapath specialize in?
Curapath specializes in non-viral drug delivery systems, including lipid nanoparticles (LNPs), targeted LNPs (tLNPs), polymer-based delivery platforms, and proprietary delivery components such as PEG alternatives. Curapath offers both off-the-shelf R&D and GMP-grade polymers and lipids, as well as custom, project-specific delivery solutions tailored to the molecule, indication, and development stage, with a strong focus on manufacturability, scalability, and regulatory readiness.
Is Curapath GMP certified and inspected by regulatory agencies
Yes. Curapath operates under GMP standards and is GMP certified. Our facilities have been inspected by both the European Medicines Agency, supporting programs intended for European and U.S. clinical and commercial supply.
Does Curapath supply products at commercial scale?
Yes. Curapath currently supplies products at commercial scale and supports more than 15 clinical trials, demonstrating its ability to deliver robust, reproducible manufacturing beyond clinical development. Curapath’s commercial supply includes polymer-based excipients, such as a PEG-copolymer and an additional polymeric excipient, manufactured under GMP conditions for regulated pharmaceutical applications.
Does Curapath develop PEG alternatives and delivery components?
Yes. Curapath develops and manufactures advanced delivery components, including PEG alternatives designed to address limitations associated with PEGylation, such as immunogenicity and long-term safety concerns.
This alternatives can be used for both LNP formulations and Protein conjugation
Who does Curapath work with?
Curapath works with biotech startups, scale-ups, and pharmaceutical companies developing advanced therapies that require specialized expertise in non-viral drug delivery and complex manufacturing processes.
Does Curapath offer solutions for specific markets or applications?
Yes. Curapath supports regulated pharmaceutical and medical device applications, developing delivery systems, components, and functional polymer materials tailored to the specific technical, regulatory, and manufacturing requirements of each market.
Curapath’s solutions address a range of advanced therapeutic areas, including oncology, cell and gene therapy, DNA and mRNA vaccines, medical devices, and programs developing in vivo CAR-T therapies.
